Clinical Psychopharmacology Institute Faculty
“The content was timely and very applicable to my practice. I also loved that this was a program designed by and for psych nurses.” – CPI Attendee
KEYNOTE SPEAKER
Nora Volkow, MD
Director of the National Institute on Drug Abuse (NIDA)
Dr. Nora D. Volkow, M.D., is the Director of the National Institute on Drug Abuse (NIDA), the world’s largest funder of scientific research on the health aspects of drug use and addiction. Her work has been instrumental in demonstrating that drug addiction is a brain disorder and she has pioneered the use of brain imaging to investigate how substance use affects brain functions. Her studies have documented how changes in the dopamine system affect the functions of brain regions involved with reward and self-control in addiction. She has also made vast contributions to the neurobiology of obesity, ADHD, and aging.
Dr. Volkow earned her medical degree from the National University of Mexico in Mexico City and completed her psychiatric residency at New York University. Much of her career was spent at the Department of Energy’s Brookhaven National Laboratory, where she held several leadership positions, including Director of Nuclear Medicine, Chairman of the Medical Department, and Associate Laboratory Director for Life Sciences. Dr. Volkow was also a professor in the Department of Psychiatry and Associate Dean of the Medical School at The State University of New York at Stony Brook. She has published almost a thousand peer-reviewed articles, written 113 book chapters, and co-edited “Neuroscience in the 21st Century.” Dr. Volkow has received various honors, including the Nathan Davis Award for Outstanding Government Service, the Samuel J. Heyman Service to America Medal, and membership in the National Academy of Medicine. She was named one of Time magazine’s “Top 100 People Who Shape Our World” and has been recognized by Washingtonian magazine, U.S. News & World Report, and Fortune for her leadership in health and science
Featuring speakers with expert knowledge and various backgrounds…
David C. Agor, DNP, PMHNP-BC, HIVPCP, PhD
Student, University of Pennsylvania, School of Nursing
Presentation teaser: Psychopharmacology in the context of PMH prescribing, nutrition, and the microbiome.
Lydia Anne M Bartholow, DNP, PMHNP, CARN-AP
Assistant Professor, UCSF School of Nursing, School of Community Health Systems
Presentation teaser: Coming soon!
Jose M. Cruz, DNP, APRN-CNP, PMHNP-BC
Clinical Manager, Psychiatry Services, Clinically Advanced APP, Level III, Psychiatric-Mental Health Nurse Practitioner, Cincinnati Children’s Hospital Medical Center
Presentation teaser: Unique psychopharmacologic considerations in the context of gender-affirming care to enhance support for the mental health of transgender patients.
Craig Heacock, MD
Adult, Adolescent, and Addiction Psychiatrist, Private Practice
Presentation teaser: Psychedelic Psychopharmacology
Presentation teaser: Bringing Therapy into Medication Management
Laura G. Leahy, DrNP, APRN, PMH-CNS/FNP, CARN-AP, FAANP, FAAN
Board Certified Psychiatric and Addictions Advanced Practice Nurse, Founder APNSolutions, LLC
Presentation teaser: How drugs are positioned in the marketplace and moving forward with patent expirations.
Jonathan M. Meyer, MD, DLFAPA
Voluntary Clinical Professor of Psychiatry, University of California, San Diego
Presentation teaser: Deep dive into medications for schizophrenia, including clozapine.
Michael T. Sorter, MD
Cincinnati Children’s Hospital Medical Center, Director, Division of Child and Adolescent Psychiatry
Presentation teaser: Treatment approaches to address agitation/aggression in the child and adolescent population.
Jeffrey R. Strawn, MD, FAACAP
Tenured Professor of Psychiatry, Pediatrics and Clinical & Translational Pharmacology, Department of Psychiatry & Behavioral Neuroscience, University of Cincinnati
Presentation teaser: Evidence-based approaches to prescribing antidepressants for children and adolescents, exploring when and how to use pharmacogenetic testing, augmentation strategies, and consideration of clinical factors.
Tony Thrasher, D.O., MBA, CPE, DFAPA
Medical Director of Crisis Services, Milwaukee County Behavioral Health Division
Presentation teaser: Areas of risk when practicing clinical medicine and best ways to mitigate these concerns, and the synergy present in skilled documentation in the Era of the Open Note.
